ID   MTLn2
AC   CVCL_8133
DR   Wikidata; Q54907008
RX   PubMed=6950180;
RX   PubMed=9397155;
RX   PubMed=21104427;
CC   Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
CC   Breed/subspecies: Fischer 344.
DI   NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_8136 ! MTLn3
SX   Female
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 29-06-23; Version: 8
//
RX   PubMed=6950180; DOI=10.1093/jnci/68.3.507;
RA   Neri A., Welch D., Kawaguchi T., Nicolson G.L.;
RT   "Development and biologic properties of malignant cell sublines and
RT   clones of a spontaneously metastasizing rat mammary adenocarcinoma.";
RL   J. Natl. Cancer Inst. 68:507-517(1982).
//
RX   PubMed=9397155; DOI=10.1002/(SICI)1097-4652(199801)174:1<48::AID-JCP6>3.0.CO;2-G;
RA   Cavanaugh P.G., Nicolson G.L.;
RT   "Selection of highly metastatic rat MTLn2 mammary adenocarcinoma cell
RT   variants using in vitro growth response to transferrin.";
RL   J. Cell. Physiol. 174:48-57(1998).
//
RX   PubMed=21104427; DOI=10.1007/s10585-010-9362-8;
RA   Dabbous M.K., Jefferson M.M., Haney L., Thomas E.L.;
RT   "Biomarkers of metastatic potential in cultured adenocarcinoma
RT   clones.";
RL   Clin. Exp. Metastasis 28:101-111(2011).
//